ATRA vs BA · rev $128.9M vs P/E 89, rev $89.46B
Atara Biotherapeutics Inc (ATRA) versus The Boeing Company (BA) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
ATRA currently screens at market cap $87.1M. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Not investment advice. Open the ATRA and BA stock pages for the full models.
Not investment advice.